Dr. Michael Baran is Executive Director, Pfizer Worldwide Research and Development and a Partner at Pfizer Ventures, where he is responsible for identifying, evaluating, making and managing equity investments aligned with the strategy of Pfizer. Prior to his current position, Mike held roles in R&D portfolio strategy as well as managing scientific affairs for the R&D President’s office at Pfizer. Mike joined Pfizer from Nexomics Biosciences, a structural biology biotech company which he co-founded. He previously worked within the NIH Protein Structure Initiative’s Northeast Structural Genomics Consortium coordinating protein structure production efforts.